Search alternatives:
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
-
1
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
-
2
Inotodiol decreases clone formation in HCC cells.
Published 2025“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”
-
3
B2 decreases glycolytic intermediates in cells.
Published 2025“…The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
-
4
-
5
-
6
-
7
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
8
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
9
EF-24 treatment significantly reduces cell viability in leukemia cell lines.
Published 2025Subjects: -
10
Voxel-based whole-hemisphere analysis shows regional and dose-dependent decrease of microglia.
Published 2025“…For the late high dose treatment, the decrease in Aβ plaque count was also colocalized with decreased microglia.…”
-
11
Mechlorethamine gel causes epithelium thinning, epithelium-stroma separation, and decreased total stroma cell count.
Published 2025“…<p>A) Epithelium thickness decreased, and B) the percentage of epithelium-stroma separation increased after NM exposure. …”
-
12
-
13
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
14
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
15
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
16
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…AGs have played a significant role in clinical practice in recent years.…”
-
17
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…AGs have played a significant role in clinical practice in recent years.…”
-
18
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
19
-
20
Pan-cancer analyses of ACADM expression and its prognostic significance in the TCGA database.
Published 2025Subjects: